Role of myeloid cells, their mediators and their antibody receptors in allergic shock (anaphylaxis) using humanized mouse models and clinical samples

Projektinformationen

MYELOSHOCK

ID Finanzhilfevereinbarung: 616050

Projekt abgeschlossen

Startdatum 1 September 2014

Enddatum 31 August 2020

Finanziert unter

• Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 1 999 704,00

EU-Beitrag € 1 999 704,00

Koordiniert durch

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France